Results 191 to 200 of about 17,474,409 (256)

Clinical Application of Artificial Intelligence in the Management of Chronic Hepatitis B

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Chronic hepatitis B (CHB) burdens the healthcare system, affecting millions of individuals worldwide with a potential progression to complications such as cirrhosis and hepatocellular carcinoma (HCC). The World Health Organization launched the chronic viral hepatitis elimination plan which aimed to eliminate chronic hepatitis B virus by 2030 ...
Jimmy Che‐To Lai, Xiaoqing Guo, Xinyan Zong, Nana Peng, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Pong‐Chi Yuen, Grace Lai‐Hung Wong   +7 more
wiley   +1 more source

Nanoparticles in Periodontology and Implant Dentistry: From Mechanisms to Clinical Applications

Journal of Periodontal Research, EarlyView.
Nanotechnology holds significant promise in improving dental care, yet there is a need for more reliable clinical studies to validate its effectiveness and safety. ABSTRACT Recent advances in nanotechnology are reshaping the landscape of periodontology and implant dentistry, particularly through the application of nanoparticles (NPs).
Chun Xu, Yuan Chen, Mario Romandini, Håvard Jostein Haugen, Sašo Ivanovski   +4 more
wiley   +1 more source

The Oral‐Hepatic Axis: Epidemiological and Mechanistic Links Between Periodontal and Liver Diseases

Journal of Periodontal Research, EarlyView.
This review summarizes current epidemiological, clinical and mechanistic evidence linking periodontitis and chronic liver diseases, highlighting the oral‐gut‐liver axis, shared immunometabolic and nutritional pathways and opportunities for integrated preventive and therapeutic strategies.
Sinem Esra Sahingur, Kinga Grzech‐Leśniak, Samuel F. Suslavich, Janina Golob Deeb   +3 more
wiley   +1 more source

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

Understanding extracellular vesicle biology, isolation, and characterization: The theory of EV‐erything

Periodontology 2000, EarlyView.
Abstract Background Extracellular vesicles (EVs), especially exosomes, are nanoparticles increasingly recognized as key regulators of intercellular communication in both physiological and pathological aspects. Despite rapid progress, inconsistencies in nomenclature, isolation, and characterization continue to restrict translational advancement.
Paras Ahmad, Nima Farshidfar, Nathan E. Estrin, Yulan Wang, Yufeng Zhang, Anton Sculean, Richard J. Miron   +6 more
wiley   +1 more source

Periodontitis and metabolic dysfunction‐associated steatotic liver disease

Periodontology 2000, EarlyView.
Abstract Objective Periodontitis is a chronic inflammatory disease with systemic effects that extend beyond the oral cavity and contribute to systemic immune and metabolic dysregulation. Chronic liver diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive phenotypes, have emerged as major global ...
Rafael Scaf de Molon, Erica Dorigatti de Avila, Davi da Silva Barbirato, Mariana Fampa Fogacci, Jamil Awad Shibli, Anton Sculean, Alpdogan Kantarci   +6 more
wiley   +1 more source

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

Transplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia, Britta L. Hirsch, Irene A. Abela, Karen E. Doucette   +3 more
wiley   +1 more source

Integrated Screening for Communicable and Non‐Communicable Diseases Multimorbidity in Low‐ and Middle‐Income Countries: A Scoping Review

Tropical Medicine &International Health, EarlyView.
ABSTRACT Multimorbidity is a growing public health challenge in low‐ and middle‐income countries (LMICs), where resource‐limited and fragmented health systems impede coordinated disease detection and management. Integrated screening offers a promising strategy to improve early detection of communicable and non‐communicable diseases.
Evans Duah, Nyeleti Chauke, Smangaliso Morerwa, Kuhlula Maluleke, Gabrielle Thompson, George Obeng Adjei, Paramjit Gill, Tivani Mashamba‐Thompson   +7 more
wiley   +1 more source

Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation

Transfusion, EarlyView.
Abstract Background Newly positive hepatitis B virus (HBV) serologic results after allogeneic hematopoietic cell transplantation (HCT) may reflect passive antibody transfer from blood‐derived products rather than HBV infection. We investigated the incidence and temporal patterns of hepatitis B surface antibody (anti‐HBs) and antibody to hepatitis B ...
Takaaki Konuma, Maki Monna‐Oiwa, Etsuko Nagai, Seiko Kato, Shohei Andoh, Junichi Kuroda, Satoshi Takahashi, Yasuhito Nannya   +7 more
wiley   +1 more source

Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’

Vox Sanguinis, EarlyView.
Monica Chaves, Martina Schaetzl, Florina Pessl   +2 more
wiley   +1 more source